Copley Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$271K Sell
747
-444
-37% -$152K 0.16% 91
2026
Q1
$419K Sell
1,191
-102
-8% -$36.4K 0.25% 64
2025
Q4
$423K Sell
1,293
-97
-7% -$30.8K 0.26% 65
2025
Q3
$392K Sell
1,390
-46
-3% -$13.3K 0.27% 71
2025
Q2
$401K Sell
1,436
-133
-8% -$37.7K 0.3% 71
2025
Q1
$489K Sell
1,569
-30
-2% -$8.86K 0.37% 57
2024
Q4
$417K Buy
1,599
+277
+21% +$82.2K 0.32% 78
2024
Q3
$426K Buy
+1,322
New +$432K 0.39% 74

Other funds holding AMGN

Copley Financial Group's AMGN Position: Q2 2026 in Review

Copley Financial Group reduced its Amgen (AMGN) stake by 37% in Q2 2026, selling an estimated $152K and leaving 747 shares worth $271K. The position accounts for 0.16% of the portfolio, ranked #91.

Copley Financial Group first reported a position in AMGN in Q3 2024 and has held it in 8 quarters since. The position peaked at $489K in Q1 2025. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Copley Financial Group held 747 shares of Amgen worth $271K as of Q2 2026.
  • Copley Financial Group sold 444 Amgen shares in Q2 2026, an estimated $152K.
  • Amgen made up 0.16% of Copley Financial Group's portfolio in Q2 2026, its #91 holding.
  • Copley Financial Group first reported a position in Amgen in Q3 2024 and has held it in 8 quarters since.
  • Copley Financial Group's Amgen position peaked at $489K in Q1 2025.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Copley Financial Group's 13F filing for Q2 2026, filed 11 Aug 2026.